Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mirco J Friedrich

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Blood|June 26, 2025
When the silence speaks: T-cell dysfunction in myelomaMirco J Friedrich, Marc S Raab
Nature Biotechnology|August 12, 2025
Targeted delivery of diverse biomolecules with engineered bacterial nanosyringesJoseph Kreitz, Victoria Yang, Mirco J Friedrich, et al.
Nature Communications|August 23, 2023
Cell type-specific delivery by modular envelope designDaniel Strebinger, Chris J Frangieh, Mirco J Friedrich, et al.
Nature|March 29, 2023
Programmable protein delivery with a bacterial contractile injection systemJoseph Kreitz, Mirco J Friedrich, Akash Guru, et al.
Nature Biotechnology|September 23, 2024
Chemical and topological design of multicapped mRNA and capped circular RNA to augment translationHongyu Chen, Dangliang Liu, Abhishek Aditham, et al.
Nature|December 17, 2025
Transient hepatic reconstitution of trophic factors enhances aged immunityMirco J Friedrich, Julie Pham, Jiakun Tian, et al.
Nature Communications|January 3, 2025
Rational engineering of minimally immunogenic nucleases for gene therapyRumya Raghavan, Mirco J Friedrich, Indigo King, et al.
Biorxiv : the Preprint Server for Biology|July 9, 2025
Tissue architecture dynamics underlying immune development and decline in the thymusSophia Liu, Mirco J Friedrich, Ruth Raichur, et al.
Blood Advances|June 12, 2026
High-risk single-refractory and double-refractory chronic lymphocytic leukemia: feasibility and impact of alloHCTJoseph Kauer, Isabelle Krämer, Patrick Derigs, et al.
Cancer Cell|March 10, 2023
The pre-existing T cell landscape determines the response to bispecific T cell engagers in multiple myeloma patientsMirco J Friedrich, Paola Neri, Niklas Kehl, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Blood|June 26, 2025
When the silence speaks: T-cell dysfunction in myelomaMirco J Friedrich, Marc S Raab
Nature Biotechnology|August 12, 2025
Targeted delivery of diverse biomolecules with engineered bacterial nanosyringesJoseph Kreitz, Victoria Yang, Mirco J Friedrich, et al.
Nature Communications|August 23, 2023
Cell type-specific delivery by modular envelope designDaniel Strebinger, Chris J Frangieh, Mirco J Friedrich, et al.
Nature|March 29, 2023
Programmable protein delivery with a bacterial contractile injection systemJoseph Kreitz, Mirco J Friedrich, Akash Guru, et al.
Nature Biotechnology|September 23, 2024
Chemical and topological design of multicapped mRNA and capped circular RNA to augment translationHongyu Chen, Dangliang Liu, Abhishek Aditham, et al.
Nature|December 17, 2025
Transient hepatic reconstitution of trophic factors enhances aged immunityMirco J Friedrich, Julie Pham, Jiakun Tian, et al.
Nature Communications|January 3, 2025
Rational engineering of minimally immunogenic nucleases for gene therapyRumya Raghavan, Mirco J Friedrich, Indigo King, et al.
Biorxiv : the Preprint Server for Biology|July 9, 2025
Tissue architecture dynamics underlying immune development and decline in the thymusSophia Liu, Mirco J Friedrich, Ruth Raichur, et al.
Blood Advances|June 12, 2026
High-risk single-refractory and double-refractory chronic lymphocytic leukemia: feasibility and impact of alloHCTJoseph Kauer, Isabelle Krämer, Patrick Derigs, et al.
Cancer Cell|March 10, 2023
The pre-existing T cell landscape determines the response to bispecific T cell engagers in multiple myeloma patientsMirco J Friedrich, Paola Neri, Niklas Kehl, et al.
Pageof 2